George D. Kalliolias M.D. Ph.D.
George D. Kalliolias M.D. Ph.D.
Asst Professor, Weill Cornell Medical College, Asst Scientist, Hospital for Special Surgery
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα
Παρατίθεται από
Παρατίθεται από
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
GD Kalliolias, LB Ivashkiv
Nature Reviews Rheumatology 12 (1), 49-62, 2016
Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins
L Wang, RA Gordon, L Huynh, X Su, KHP Min, J Han, JS Arthur, ...
Immunity 32 (4), 518-530, 2010
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
PDA Issuree, T Maretzky, DR McIlwain, S Monette, X Qing, PA Lang, ...
The Journal of clinical investigation 123 (2), 928-932, 2013
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38
GD Kalliolias, LB Ivashkiv
The Journal of Immunology 180 (9), 6325-6333, 2008
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
GD Kalliolias, SN C Liossis
Expert opinion on investigational drugs 17 (3), 349-359, 2008
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
F Mizoguchi, K Slowikowski, K Wei, JL Marshall, DA Rao, SK Chang, ...
Nature communications 9 (1), 1-11, 2018
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages
A Triantafyllopoulou, CW Franzke, SV Seshan, G Perino, GD Kalliolias, ...
Proceedings of the National Academy of Sciences 107 (7), 3012-3017, 2010
Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial
GD Kalliolias, PE Georgiou, IA Antonopoulos, AP Andonopoulos, ...
Annals of the Rheumatic Diseases 66 (6), 842-843, 2007
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts
A Lee, Y Qiao, G Grigoriev, J Chen, KH Park‐Min, SH Park, LB Ivashkiv, ...
Arthritis & Rheumatism 65 (4), 928-938, 2013
Overview of the biology of type I interferons
GD Kalliolias, LB Ivashkiv
Arthritis research & therapy 12 (1), 1-9, 2010
Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
GD Kalliolias, B Zhao, A Triantafyllopoulou, KH Park‐Min, LB Ivashkiv
Arthritis & Rheumatism: Official Journal of the American College of …, 2010
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27
GD Kalliolias, RA Gordon, LB Ivashkiv
The Journal of Immunology 185 (11), 7047-7056, 2010
Modulation of TNF-induced macrophage polarization by synovial fibroblasts
LT Donlin, A Jayatilleke, EG Giannopoulou, GD Kalliolias, LB Ivashkiv
The Journal of Immunology 193 (5), 2373-2383, 2014
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter‐regulated by …
RA Gordon, G Grigoriev, A Lee, GD Kalliolias, LB Ivashkiv
Arthritis & rheumatism 64 (10), 3119-3128, 2012
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease
G Yiannopoulos, V Pastromas, I Antonopoulos, G Katsiberis, G Kalliolias, ...
Rheumatology international 27 (4), 357-361, 2007
Pharmacogenetic principles in the Hippocratic writings
GP Sykiotis, GD Kalliolias, AG Papavassiliou
The Journal of Clinical Pharmacology 45 (11), 1218-1220, 2005
Prolonged tumor necrosis factor α primes fibroblast‐like synoviocytes in a gene‐specific manner by altering chromatin
C Sohn, A Lee, Y Qiao, K Loupasakis, LB Ivashkiv, GD Kalliolias
Arthritis & Rheumatology 67 (1), 86-95, 2015
Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis
SD Chakravarty, PI Poulikakos, LB Ivashkiv, JE Salmon, GD Kalliolias
Clinical Immunology 148 (1), 66-78, 2013
Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
G Iconomou, A Koutras, K Karaivazoglou, GD Kalliolias, ...
European journal of cancer care 17 (6), 535-541, 2008
The impact of disease activity and tumor necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis
W HM, P N, L TJ, A A, K GD, Z YS, S F, N J, S L, Cunningham-Rundles S, ...
Clin Exp Immunol., 2016
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20